Medicare Enrolled
Dr. Deepa Panjeti-Moore, D.O.
Neurology · Dallas, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Panjeti-Moore from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Panjeti-Moore?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Panjeti-Moore
Dr. Deepa Panjeti-Moore is a neurology specialist in Dallas, TX, with 12 years of NPI registration. Based on federal Medicare data, Dr. Panjeti-Moore performed 507 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Panjeti-Moore received a total of $41,429 from 50 pharmaceutical and/or device companies across 335 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Panjeti-Moore is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years of NPI registration
▲ Top 49% volume in TX
$41,429 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗507
Medicare services
Top 49% in TX for neurology
Not available
Unique patients (not deduplicated)
$146
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
146 | $133 | $274 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
108 | $94 | $215 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
53 | $310 | $925 |
| New patient office visit, complex (60-74 min) | 35 | $152 | $535 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
25 | $98 | $871 |
| VEEG monitoring, 12-26 hours with review This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report. |
22 | $162 | $3,210 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
21 | $347 | $1,105 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
18 | $95 | $256 |
| Continuous EEG brain wave monitoring A test that records electrical activity in the brain over an extended period. It is used to monitor brain function continuously. |
14 | $178 | $3,190 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
14 | $102 | $325 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
14 | $26 | $225 |
| Psychological test administration, each additional 30 minutes A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time. |
14 | $26 | $225 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
12 | $134 | $300 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $121 | $425 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$41,429
Total received (2018-2024)
Avg $6,905/year across 6 years
Top 11% in TX for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
335
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$19,581
2023
$18,941
2022
$1,707
2021
$977
2020
$12
2018
$211
Payments by company (2024)
Neurelis, Inc.
$9,558
NEUROPACE, INC.
$5,820
SK Life Science, Inc.
$2,565
LivaNova USA, Inc.
$466
UCB, Inc.
$305
ABBVIE INC.
$228
Teva Pharmaceuticals USA, Inc.
$70
Lilly USA, LLC
$68
Alexion Pharmaceuticals, Inc.
$61
Neurocrine Biosciences, Inc.
$55
ACADIA Pharmaceuticals Inc
$52
CATALYST PHARMACEUTICALS, INC.
$50
Grifols USA, LLC
$44
PFIZER INC.
$34
Marinus Pharmaceuticals, Inc.
$28
Ipsen Biopharmaceuticals, Inc
$27
JAZZ PHARMACEUTICALS INC.
$27
Lundbeck LLC
$24
Life Molecular Imaging Ltd
$20
Novartis Pharmaceuticals Corporation
$18
Amneal Pharmaceuticals LLC
$17
HOSPIRA, INC.
$16
Celgene Corporation
$14
GE HEALTHCARE
$14
Top 3 companies account for 91.6% of 2024 payments
All-time payments by company (2018-2024) ›
SK Life Science, Inc.
$14,546
Neurelis, Inc.
$13,336
NEUROPACE, INC.
$7,578
UCB, Inc.
$1,414
LivaNova USA, Inc.
$968
ABBVIE INC.
$852
Sunovion Pharmaceuticals Inc.
$267
Lilly USA, LLC
$173
Genentech USA, Inc.
$167
PFIZER INC.
$143
Teva Pharmaceuticals USA, Inc.
$142
Neurocrine Biosciences, Inc.
$125
Biohaven Pharmaceuticals, Inc.
$123
Lundbeck LLC
$106
Sumitomo Pharma America, Inc.
$100
EISAI INC.
$100
ACADIA Pharmaceuticals Inc
$89
Biohaven Pharmaceutical Holding Company Ltd.
$88
Novartis Pharmaceuticals Corporation
$86
Grifols USA, LLC
$79
JAZZ PHARMACEUTICALS INC.
$75
Ipsen Biopharmaceuticals, Inc
$72
Alexion Pharmaceuticals, Inc.
$61
Medtronic, Inc.
$60
Amneal Pharmaceuticals LLC
$58
Celgene Corporation
$52
Merz Pharmaceuticals, LLC
$51
CATALYST PHARMACEUTICALS, INC.
$50
Amgen Inc.
$46
HOSPIRA, INC.
$36
Horizon Therapeutics plc
$30
Marinus Pharmaceuticals, Inc.
$28
Eisai Inc.
$27
Jazz Pharmaceuticals Inc.
$27
CSL Behring
$23
Corium, LLC
$21
Life Molecular Imaging Ltd
$20
AbbVie Inc.
$20
Takeda Pharmaceuticals U.S.A., Inc.
$19
Biogen, Inc.
$18
Exeltis, USA Inc.
$18
EMD Serono, Inc.
$18
TG THERAPEUTICS, INC.
$17
Otsuka America Pharmaceutical, Inc.
$16
Harmony Biosciences LLC
$15
UPSHER-SMITH LABORATORIES LLC
$15
GE HEALTHCARE
$14
MITSUBISHI TANABE PHARMA AMERICA, INC.
$14
NS Pharma, Inc.
$13
ARBOR PHARMACEUTICALS, INC.
$12
Top 3 companies account for 85.6% of all-time payments
Associated products mentioned in payments ›
ACTIVA · ADUHELM · AMYVID · APTIOM · AUSTEDO · Adlarity · Aimovig · Austedo XR · BOTOX · BRIUMVI · Briviact · COMIRNATY · DAYBUE · DYSPORT · Dysport · EMGALITY · EPIDIOLEX · Enspryng · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · Gamunex-C · Hizentra · Horizant · INGREZZA · KESIMPTA · KYNMOBI · NEURACEQ · NUEDEXTA · NURTEC ODT · Nayzilam · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · Ongentys · PAXLOVID · PURIFIED CORTROPHIN GEL · QULIPTA · RADICAVA · RNS Neurostimulator Kit · RYTARY · TOSYMRA · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VILTEPSO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy SenTiva Model 1000 Generator · VYALEV · VYEPTI · Wakix · XCOPRI · Xeomin · ZEPOSIA · ZTALMY
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
237
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
NEXUS CHILDRENS HOSPITAL DALLAS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Panjeti-Moore is a clinical cardiology specialist, with moderate Medicare volume.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Panjeti-Moore experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Panjeti-Moore performed 146 office visit, established patient, complex (40-54 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Panjeti-Moore receive payments from pharmaceutical companies?
Yes. Dr. Panjeti-Moore received a total of $41,429 from 50 companies across 335 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Panjeti-Moore's costs compare to other neurologists in Dallas?
Dr. Panjeti-Moore's average Medicare payment per service is $146. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Panjeti-Moore) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Dallas
Browse neurologists in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in TX
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in TX
Which TX neurologists receive the most from drug and device companies.
By company
SK Life Science, Inc. Payments to Doctors
See all physicians who received payments from SK Life Science, Inc.
By company
Neurelis, Inc. Payments to Doctors
See all physicians who received payments from Neurelis, Inc.
By company
NEUROPACE, INC. Payments to Doctors
See all physicians who received payments from NEUROPACE, INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology